Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1996 1
2000 1
2010 1
2014 1
2017 2
2018 1
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Loop diuretic therapy in liver cirrhosis with ascites.
Laffi G, La Villa G, Carloni V, Foschi M, Bartoletti L, Quartini M, Gentilini P. Laffi G, et al. Among authors: quartini m. J Cardiovasc Pharmacol. 1993;22 Suppl 3:S51-8. doi: 10.1097/00005344-199322003-00007. J Cardiovasc Pharmacol. 1993. PMID: 7506337 Review.
Liver stiffness, a non-invasive marker of liver disease: a core study group report.
Bonino F, Arena U, Brunetto MR, Coco B, Fraquelli M, Oliveri F, Pinzani M, Prati D, Rigamonti C, Vizzuti F; Liver Stiffness Study Group 'Elastica' of the Italian Association for the Study of the Liver. Bonino F, et al. Antivir Ther. 2010;15 Suppl 3:69-78. doi: 10.3851/IMP1626. Antivir Ther. 2010. PMID: 21041906
Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement.
Testino G, Burra P, Bonino F, Piani F, Sumberaz A, Peressutti R, Giannelli Castiglione A, Patussi V, Fanucchi T, Ancarani O, De Cerce G, Iannini AT, Greco G, Mosti A, Durante M, Babocci P, Quartini M, Mioni D, Aricò S, Baselice A, Leone S, Lozer F, Scafato E, Borro P; Group of Italian Regions. Testino G, et al. Among authors: quartini m. World J Gastroenterol. 2014 Oct 28;20(40):14642-51. doi: 10.3748/wjg.v20.i40.14642. World J Gastroenterol. 2014. PMID: 25356027 Free PMC article. Review.
Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
Rinaldi L, Messina V, Di Marco V, Iovinella V, Claar E, Cariti G, Sacco R, De Luca M, Scifo G, Gatti P, Barbarini G, Pace Palitti V, Quartini M, Tundo P, D'Offizi G, Parruti G, di Rosolini MA, Garrucciu G, Cosco L, Benanti F, Gimignani G, Vespasiani Gentilucci U, Di Lorenzo F, D'Antò M, Nevola R, Lupia T, Rosato V, Morbiducci V, Luzzitelli I, Sozio F, Di Stefano M, Ciraci E, Bulla F, Guarisco R, Cangiano C, Imparato M, Maggi P, Ascione A, Craxì A, Izzi A. Rinaldi L, et al. Among authors: quartini m. Am J Gastroenterol. 2021 Jun 1;116(6):1248-1255. doi: 10.14309/ajg.0000000000001147. Am J Gastroenterol. 2021. PMID: 34074828
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey.
Pezzilli R, Buscarini E, Pollini T, Bonamini D, Marchegiani G, Crippa S, Belfiori G, Sperti C, Moletta L, Pozza G, De Nucci G, Manes G, Mandelli ED, Casadei R, Ricci C, Alicante S, Vattiato C, Carrara S, Di Leo M, Fabbri C, Giovanelli S, Barresi L, Tacelli M, Mirante VG, Conigliaro R, Antonini F, Macarri G, Frulloni L, De Marchi G, Sassatelli R, Cecinato P, Del Vecchio Blanco G, Galli A, Pezzullo A, Fantin A, Graffeo M, Frego M, Stillittano D, Monica F, Germanà B, Capurso G, Quartini M, Veneroni L, Cannizzaro R, Falconi M. Pezzilli R, et al. Among authors: quartini m. Dig Liver Dis. 2020 May;52(5):547-554. doi: 10.1016/j.dld.2020.02.003. Epub 2020 Feb 29. Dig Liver Dis. 2020. PMID: 32122771 Free article.
Rifaximin in the treatment of chronic hepatic encephalopathy.
Puxeddu A, Quartini M, Massimetti A, Ferrieri A. Puxeddu A, et al. Among authors: quartini m. Curr Med Res Opin. 1995;13(5):274-81. doi: 10.1185/03007999509111552. Curr Med Res Opin. 1995. PMID: 7555036 Clinical Trial.
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.
Ascione A, De Luca M, Melazzini M, Montilla S, Trotta MP, Petta S, Puoti M, Sangiovanni V, Messina V, Bruno S, Izzi A, Villa E, Aghemo A, Zignego AL, Orlandini A, Fontanella L, Gasbarrini A, Marzioni M, Giannini EG, Craxì A; ABACUS Study Group. Ascione A, et al. Infection. 2018 Oct;46(5):607-615. doi: 10.1007/s15010-018-1157-x. Epub 2018 May 28. Infection. 2018. PMID: 29808463
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study.
Petta S, Marzioni M, Russo P, Aghemo A, Alberti A, Ascione A, Antinori A, Bruno R, Bruno S, Chirianni A, Gaeta GB, Giannini EG, Merli M, Messina V, Montilla S, Perno CF, Puoti M, Raimondo G, Rendina M, Silberstein FC, Villa E, Zignego AL, Pani L, Craxì A; ABACUS study group; AIFA team. Petta S, et al. Lancet Gastroenterol Hepatol. 2017 Jun;2(6):427-434. doi: 10.1016/S2468-1253(17)30048-1. Epub 2017 Apr 10. Lancet Gastroenterol Hepatol. 2017. PMID: 28497758
11 results